CymaBay Therapeutics, Inc.

D. E. Shaw & Co., Inc.

Report date

12/31/2023

Quarter

2023 Q4

Filed

2/14/2024

Shares

636,897

Value ($000)

15,044

Weight

0.0%

2019 Q4 - 2023 Q4 (17 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2023 Q4	2/14/2024	15,044	0.0%	636,897	12/31/2023
2023 Q3	11/14/2023	11,898	0.0%	798,009	9/30/2023
2023 Q2	8/14/2023	7,582	0.0%	692,401	6/30/2023
2023 Q1	5/15/2023	4,788	0.0%	549,044	3/31/2023
2022 Q4	2/14/2023	1,682	0.0%	268,195	12/31/2022
2022 Q3	11/14/2022	786	0.0%	224,613	9/30/2022
2022 Q2	8/15/2022	782	0.0%	265,341	6/30/2022
2022 Q1	5/16/2022	965	0.0%	310,282	3/31/2022
2021 Q4	2/14/2022	835	0.0%	246,788	12/31/2021
2021 Q3	11/15/2021	1,273	0.0%	348,698	9/30/2021
2021 Q2	8/16/2021	2,602	0.0%	596,727	6/30/2021
2021 Q1	5/17/2021	4,343	0.0%	956,521	3/31/2021
2020 Q4	2/16/2021	7,237	0.0%	1,260,749	12/31/2020
2020 Q3	11/16/2020	12,196	0.0%	1,684,486	9/30/2020
2020 Q2	8/14/2020	11,815	0.0%	3,385,172	6/30/2020
2020 Q1	5/15/2020	3,582	0.0%	2,419,884	3/31/2020
2019 Q4	2/14/2020	3,962	0.0%	2,021,552	12/31/2019